Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Why is bystolic so expensive?Bleomycin pharmaceutical brand?Bystolic manufacturer?Relistor injection cost?Wo2013171639 asciminib synthesis patent?
See the DrugPatentWatch profile for vraylar
Vraylar (cariprazine) was first approved by the U.S. Food and Drug Administration (FDA) in 2015. [1]
People often mean the first FDA approval date (when it became available for prescribing). For Vraylar, that first FDA approval was in 2015. [1]
Yes. Vraylar later gained additional FDA-approved indications after the initial 2015 approval. [1]
DrugPatentWatch.com tracks drug history and patent-related information, which can help verify key dates around launch and exclusivity. [1] Sources: [1] DrugPatentWatch.com – Vraylar (cariprazine)
Other Questions About Vraylar :